Overview

Aesthetic medicine is undergoing a quiet but significant shift. Rather than focusing solely on relaxing muscles or replacing lost volume, modern regenerative aesthetics is increasingly centred on restoring skin biology itself. Polynucleotides represent one of the most important developments in this shift.

Used within a medical framework, polynucleotides support cellular repair, tissue regeneration, and skin resilience, helping improve skin quality from the inside out — without altering facial structure or expression.

What Are Polynucleotides in Aesthetic Medicine? 

Polynucleotides are biologically active molecules derived from DNA fragments that support cellular repair and regeneration. In aesthetic medicine, they are used to stimulate fibroblast activity, improve skin hydration, support collagen synthesis, and enhance tissue recovery at a cellular level.

Rather than “filling” or “freezing” the face, polynucleotides work by supporting the skin’s natural repair mechanisms, making them particularly suited for patients seeking subtle, regenerative improvement.

How Polynucleotides Work at the Cellular Level

Skin health depends on the function of its cells — particularly fibroblasts, which are responsible for collagen, elastin, and extracellular matrix production. Over time, inflammation, oxidative stress, and ageing impair this cellular activity.

Polynucleotides act by:

Supporting fibroblast activation and survival
Enhancing cellular repair and tissue regeneration
Improving skin hydration and elasticity
Modulating inflammatory responses within the dermis
Creating a biological environment that supports long-term skin resilience
This mechanism makes polynucleotides fundamentally different from traditional aesthetic injectables.

Polynucleotides vs Fillers: A Different Therapeutic Intent

While dermal fillers are designed to restore volume or structural support, polynucleotides are focused on skin quality and tissue health.

Key differences include:

No volumisation or contour change
No alteration of facial anatomy
Gradual, biological improvement rather than immediate cosmetic effect
Support for collagen and skin repair over time

For many patients, polynucleotides are appropriate when the primary concern is skin texture, elasticity, hydration, or early ageing, rather than volume loss.

Who May Benefit from Polynucleotide Therapy

Polynucleotide-based regenerative treatments may be considered for individuals who:

Notice dull, tired, or thinning skin
Have early signs of ageing without significant volume loss
Experience reduced skin elasticity or hydration
Want regenerative support without changing facial structure
Prefer biologically driven, physician-led aesthetic care

As with all regenerative therapies at Proto Clinic, suitability is determined following medical and aesthetic assessment, not trend or demand.

Why Clinical Oversight Matters

Not all regenerative treatments are equal. The effectiveness of polynucleotides depends on:

Correct patient selection
Appropriate treatment depth and technique
Integration with overall skin biology and health
Alignment with evidence and regulatory guidance

At Proto Clinic, polynucleotide therapy is delivered within a science-driven, physician-led framework, often as part of a broader regenerative skin strategy rather than a standalone cosmetic procedure.

Polynucleotides as Part of Regenerative Aesthetics

Polynucleotides reflect a broader evolution in aesthetic medicine — one that prioritises cellular signalling, tissue repair, and long-term skin health over short-term cosmetic correction.

When used appropriately, they support:

Healthier skin function
Improved resilience and recovery
Subtle, natural-looking improvement over time

They are not a replacement for all aesthetic treatments, but an important tool within bioregenerative aesthetic medicine.